Switching to IV treatments cuts out-of-pocket expenses but carries risksAs many as 40,000 chronically ill seniors are choosing to endure uncomfortable, time-consuming intravenous infusions because Medicare doesn’t sufficiently cover far more convenient, and less distressing, at-home treatments with the arthritis drug Humira.When rheumatoid arthritis patients enroll in Medicare, switching from private insurance plans, self-administered medications […]
